Candriam SCA’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-70,000
| Closed | -$6.4M | – | 660 |
|
|
2023
Q2 | $6.4M | Buy |
70,000
+44,440
| +174% | +$4.06M | 0.05% | 302 |
|
|
2023
Q1 | $1.73M | Buy |
25,560
+1,250
| +5% | +$84.6K | 0.01% | 601 |
|
|
2022
Q4 | $2.03M | Buy |
24,310
+2,028
| +9% | +$169K | 0.01% | 576 |
|
|
2022
Q3 | $2.16M | Buy |
22,282
+8,282
| +59% | +$802K | 0.02% | 567 |
|
|
2022
Q2 | $1.47M | Hold |
14,000
| – | – | 0.01% | 563 |
|
|
2022
Q1 | $2.41M | Hold |
14,000
| – | – | 0.02% | 503 |
|
|
2021
Q4 | $5.95M | Buy |
+14,000
| New | +$5.95M | 0.04% | 326 |
|